News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
621,662 Results
Type
Article (51649)
Company Profile (275)
Press Release (569738)
Section
Business (174762)
Career Advice (2540)
Deals (31884)
Drug Delivery (98)
Drug Development (77490)
Employer Resources (145)
FDA (16471)
Job Trends (13860)
News (309204)
Policy (31506)
Tag
Academia (2725)
Alliances (46884)
Alzheimer's disease (1238)
Approvals (16392)
Artificial intelligence (129)
Bankruptcy (334)
Best Places to Work (11074)
Biotechnology (197)
Breast cancer (119)
Cancer (1082)
Cardiovascular disease (96)
Career advice (2126)
Cell therapy (241)
Clinical research (61489)
Collaboration (385)
Compensation (130)
COVID-19 (2512)
C-suite (101)
Data (1108)
Diabetes (157)
Diagnostics (5804)
Drug pricing (90)
Earnings (64282)
Employer resources (129)
Events (85368)
Executive appointments (306)
FDA (17013)
Funding (352)
Gene therapy (190)
GLP-1 (605)
Government (4037)
Healthcare (17931)
Infectious disease (2596)
Inflammatory bowel disease (111)
Interviews (478)
IPO (14733)
Job creations (3179)
Job search strategy (1771)
Layoffs (372)
Legal (7128)
Lung cancer (166)
Manufacturing (177)
Medical device (11846)
Medtech (11851)
Mergers & acquisitions (17226)
Metabolic disorders (418)
Neuroscience (1520)
NextGen Class of 2024 (6186)
Non-profit (4565)
Northern California (1353)
Obesity (242)
Opinion (211)
Patents (101)
People (51267)
Phase I (18967)
Phase II (26964)
Phase III (20457)
Pipeline (453)
Postmarket research (2468)
Preclinical (8145)
Radiopharmaceuticals (242)
Rare diseases (228)
Real estate (5066)
Regulatory (21652)
Research institute (2488)
Resumes & cover letters (420)
Southern California (1219)
Startups (3303)
United States (12540)
Vaccines (563)
Weight loss (183)
Date
Today (75)
Last 7 days (637)
Last 30 days (3492)
Last 365 days (34073)
2024 (31206)
2023 (37754)
2022 (48292)
2021 (52365)
2020 (50948)
2019 (44290)
2018 (33602)
2017 (30771)
2016 (29621)
2015 (34246)
2014 (26912)
2013 (23122)
2012 (24535)
2011 (25100)
2010 (23347)
Location
Africa (828)
Arizona (125)
Asia (38067)
Australia (6445)
California (3124)
Canada (1206)
China (245)
Colorado (146)
Connecticut (145)
Europe (83845)
Florida (436)
Georgia (103)
Illinois (325)
Indiana (189)
Kansas (89)
Maryland (525)
Massachusetts (2348)
Michigan (147)
Minnesota (205)
New Jersey (921)
New York (915)
North Carolina (715)
Northern California (1353)
Ohio (133)
Pennsylvania (762)
South America (1123)
Southern California (1219)
Texas (441)
Washington State (345)
621,662 Results for "california institute for regenerative medicine".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Aspen Neuroscience Receives CLIN2 Grant for ANPD001 from California Institute for Regenerative Medicine (CIRM)
Aspen Neuroscience, Inc. has received a CLIN2 grant award of $8 million from the California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, to support clinical research aimed at treating Parkinson’s disease (PD).
May 15, 2024
·
4 min read
Press Releases
CIRM Marks 20 Years of Advancing Regenerative Medicine in California
November 15, 2024
·
3 min read
Biotech Beach
Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM) - April 30, 2024
Lineage Cell Therapeutics, Inc. today announced that the Company has received an Education Conference II Grant from the California Institute for Regenerative Medicine (CIRM).
April 30, 2024
·
9 min read
Senti Bio Awarded California Institute for Regenerative Medicines (CIRM) Grant for Clinical Development of Logic Gated CAR-NK Cell Therapy
Senti Biosciences, Inc., a biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, announced that the California Institute for Regenerative Medicines has awarded an $8 million grant to Senti Bio.
July 1, 2024
·
9 min read
BioMidwest
Andelyn Biosciences Selected as Viral Vector Manufacturing Partner for the California Institute for Regenerative Medicine (CIRM) Accelerating Medicines Partnership (AMP) Bespoke Gene Therapy Consortium (BGTC)
Andelyn Biosciences, Inc. has been selected to manufacture adeno-associated vectors therapies using its suspension AAV Curator™ Platform under the California Institute for Regenerative Medicine Accelerating Medicines Partnership Bespoke Gene Therapy Consortium.
May 23, 2024
·
3 min read
Business
Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma
Allogene Therapeutics, Inc. announced that it has received a $15 million grant from the California Institute for Regenerative Medicine (CIRM) to support the clinical development of ALLO-316, an AlloCAR T™ investigational product targeting CD70 in development for the treatment of advanced or metastatic renal cell carcinoma (RCC).
April 26, 2024
·
8 min read
Business
Forge Biologics Selected as an AAV Manufacturing Partner for California Institute for Regenerative Medicine to Help Accelerate Gene Therapy Programs
Forge Biologics (Forge), a leading manufacturer of genetic medicines, announced today that it has joined the California Institute for Regenerative Medicine’s (CIRM) Industry Resource Partner Program to help advance the manufacturing of adeno-associated adenovirus (AAV) gene therapy programs from the state of California.
October 11, 2023
·
3 min read
Press Releases
Rejuvenate Bio Receives $4M in Funding from the California Institute for Regenerative Medicine (CIRM)
Funding will advance development of Rejuvenate’s one-time gene therapy RJB-0402 for the treatment of desmoplakin gene variant arrhythmogenic cardiomyopathy
July 1, 2024
·
4 min read
Business
Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs
Avid Bioservices, Inc. announced a new partnership with the California Institute for Regenerative Medicine Industry Resource Partner Program.
November 8, 2023
·
4 min read
Press Releases
Senti Bio Announces Execution of Grant Award from California Institute for Regenerative Medicines (CIRM) for Clinical Development of SENTI-202
August 5, 2024
·
8 min read
1 of 62,167
Next